These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22091732)

  • 1. A Checklist for the Conduct, Reporting, and Appraisal of Microcosting Studies in Health Care: Protocol Development.
    Ruger JP; Reiff M
    JMIR Res Protoc; 2016 Oct; 5(4):e195. PubMed ID: 27707687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Costs of Persons with Drug Use Disorders Among Medicaid Managed Care Beneficiaries in Puerto Rico : Comparison of the Direct Services Costs Incurred by Beneficiaries With and Without a Drug Use Disorder.
    Colón Jordán HM; Laborde Rivera JE; Marín Centeno HA; Albizu-García CE
    J Behav Health Serv Res; 2016 Apr; 43(2):293-304. PubMed ID: 26219253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The globalization of addiction research: capacity-building mechanisms and selected examples.
    Rawson RA; Woody G; Kresina TF; Gust S
    Harv Rev Psychiatry; 2015; 23(2):147-56. PubMed ID: 25747927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-costing studies in the health and medical literature: protocol for a systematic review.
    Xu X; Grossetta Nardini HK; Ruger JP
    Syst Rev; 2014 May; 3():47. PubMed ID: 24887208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of a motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice for pregnant substance users.
    Xu X; Yonkers KA; Ruger JP
    PLoS One; 2014; 9(4):e95264. PubMed ID: 24760017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological maintenance treatments of opiate addiction.
    Bell J
    Br J Clin Pharmacol; 2014 Feb; 77(2):253-63. PubMed ID: 23210630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
    Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
    Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide.
    Ruger JP; Chawarski M; Mazlan M; Luekens C; Ng N; Schottenfeld R
    Health Serv Res; 2012 Apr; 47(2):865-87. PubMed ID: 22091732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
    Ruger JP; Chawarski M; Mazlan M; Ng N; Schottenfeld R
    PLoS One; 2012; 7(12):e50673. PubMed ID: 23226534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.
    Schottenfeld RS; Chawarski MC; Mazlan M
    Lancet; 2008 Jun; 371(9631):2192-200. PubMed ID: 18586174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.
    Schackman BR; Leff JA; Polsky D; Moore BA; Fiellin DA
    J Gen Intern Med; 2012 Jun; 27(6):669-76. PubMed ID: 22215271
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.